THE HILL - The Trump administration's decision not to purchase additional doses of Pfizer's COVID-19 vaccine could prove to be a risky gamble resulting in a delay of an ambitious schedule to vaccinate Americans.
The administration has a contract in place for 100 million doses of Pfizer's vaccine, enough to vaccinate only 50 million people. In addition, the company's commitments to other countries means that if the U.S. needs more doses, the company would not be able to fulfill them until the summer. The administration has decided to rely on other companies for effective inoculation in addition to Pfizer, fueling concerns that the U.S. may not be able to meet its goal of vaccinating the entire U.S. population by the spring or summer of 2021.
12/11/2020